Vaccinex (VCNX) Misses Q3 EPS by 83c

Vaccinex (NASDAQ: VCNX) reported Q3 EPS of ($1.09), $0.83 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $20 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• RenovoRx regains Nasdaq minimum bid price compliance